尤含笑;李梦涛;张奉春;曾小峰;胡朝军;
YOU Han-xiao;LI Meng-tao;ZHANG Feng-chun;ZENG Xiao-feng;HU Chao-jun;Department of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases,Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education,Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College;

• 1:中国医学科学院北京协和医学院北京协和医院风湿免疫科国家皮肤与免疫疾病临床医学研究中心风湿免疫病学教育部重点实验室

摘要(Abstract)：

神经精神性狼疮(neuropsychiatric systemic lupus erythematosus,NPSLE)是系统性红斑狼疮(systemic lupus erythematosus,SLE)病变累及神经系统而产生神经和/或精神症状的一组预后差、死亡率高的严重并发症,SLE患者血清或脑脊液中检测到的独特的自身抗体与神经精神疾病相关。在SLE患者中,NPSLE的患病率从17%至75%不等。本文论述国内外最新研究结果,着重探讨抗核糖体P抗体、抗磷脂抗体、抗神经元抗体等相关抗体在中枢神经受累的NPSLE中的研究现状及其临床价值。
Neuropsychiatric systemic lupus erythematosus(NPSLE) is a group of severe complications with a poor prognosis and high mortality caused by systemic lupus erythematosus(SLE). Its lesions involve the nervous system and cause neurological and/or psychiatric symptoms. Unique autoantibodies detected in the serum or cerebrospinal fluid of patients with NPSLE are associated with the presence of neuropsychiatric disorders. The prevalence of NPSLE ranges from 17% to 75% in SLE. This article reviewed the latest progress and focused on the current state of knowledge and the potential clinical value of anti-ribosomal P antibody, antiphospholipid antibody, anti-neuronal antibody, and other related antibodies in NPSLE with central nervous involvement.

关键词(KeyWords)： 系统性红斑狼疮;神经精神性狼疮;自身抗体
systemic lupus erythematosus;neuropsychiatric systemic lupus erythematosus;autoantibodies

Abstract:

Keywords:

基金项目(Foundation): 国家重点研发计划(2019YFC0840603);; 国家自然科学基金(81771780);; 中国医学科学院医学与健康科技创新工程(2017-I2M-3-001)

作者(Authors): 尤含笑;李梦涛;张奉春;曾小峰;胡朝军;
YOU Han-xiao;LI Meng-tao;ZHANG Feng-chun;ZENG Xiao-feng;HU Chao-jun;Department of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases,Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education,Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College;

参考文献(References)：

• [1] Rhiannon JJ.Systemic Lupus Erythematosus Involving the Nervous System:Presentation,Pathogenesis,and Management[J].Clin Rev Allergy Immunol,2008,34:356- 360.
• [2] The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes[J].Arthritis Rheum,1999,42:599- 608.
• [3] Magro-Checa C,Steup-Beekman GM,Huizinga TW,et al.Laboratory and Neuroimaging Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus:Where Do We Stand,Where To Go?[J].Front Med (Lausanne),2018,5:340.
• [4] Hanly JG,Kozora E,Beyea SD,et al.Nervous System Disease in Systemic Lupus Erythematosus:Current Status and Future Directions[J].Arthritis Rheumatol,2019,71:33- 42.
• [5] Postal M,Costallat LT,Appenzeller S.Neuropsychiatric manifestations in systemic lupus erythematosus:epidemiolo-gy,pathophysiology and management[J].CNS Drugs,2011,25:721- 736.
• [6] Hanly JG.Diagnosis and management of neuropsychiatric SLE[J].Nat Rev Rheumatol,2014,10:338- 347.
• [7] Bertsias GK,Boumpas DT.Pathogenesis,diagnosis and management of neuropsychiatric SLE manifestations[J].Nat Rev Rheumatol,2010,6:358- 367.
• [8] Weiner SM,Klein R,Berg PA.A longitudinal study of autoantibodies against central nervous system tissue and gangliosides in connective tissue diseases[J].Rheumatol Int,2000,19:83- 88.
• [9] Tsuchiya H,Haga S,Takahashi Y,et al.Identification of novel autoantibodies to GABA(B) receptors in patients with neuropsychiatric systemic lupus erythematosus[J].Rheumatology (Oxford),2014,53:1219- 1228.
• [10] Ho RC,Thiaghu C,Ong H,et al.A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus[J].Autoimmunity Reviews,2016,15:124- 138.
• [11] Karassa FB,Afeltra A,Ambrozic A,et al.Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus:an international meta-analysis[J].Arthritis Rheum,2006,54:312- 324.
• [12] Tay SH,Fairhurst AM,Mak A.Clinical utility of circulating anti-N-methyl-d-aspartate receptor subunits NR2A/B antibody for the diagnosis of neuropsychiatric syndromes in systemic lupus erythematosus and Sjogren's syndrome:An updated meta-analysis[J].Autoimmun Rev,2017,16:114- 122.
• [13] Bravo-Zehnder M,Toledo EM,Segovia-Miranda F,et al.Anti-ribosomal P protein autoantibodies from patients with neuropsychiatric lupus impair memory in mice[J].Arthritis Rheumatol,2015,67:204- 214.
• [14] Stojanovich L,Zandman-Goddard G,Pavlovich S,et al.Psychiatric manifestations in systemic lupus erythematosus[J].Autoimmun Rev,2007,6:421- 426.
• [15] Kiss E,Shoenfeld Y.Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus?[J].Clin Rev Allergy Immunol,2007,32:37- 46.
• [16] Sciascia S,Bertolaccini ML,Roccatello D,et al.Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus:a systematic review[J].J Neurol,2014,261:1706- 1714.
• [17] Hirohata S,Sakuma Y,Yanagida T,et al.Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus[J].Arthritis Res Ther,2014,16:450.
• [18] Ishizaki J,Saito K,Nawata M,et al.Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus[J].Rheumatology (Oxford),2015,54:405- 412.
• [19] Ou Y,Sun D,Sharp GC,et al.Screening of SLE sera using purified recombinant Sm-D1 protein from a baculovirus expression system[J].Clin Immunol Immunopathol,1997,83:310- 317.
• [20] Hu C,Li M,Liu J,et al.Anti-SmD1 antibodies are associated with renal disorder,seizures,and pulmonary arterial hypertension in Chinese patients with active SLE[J].Sci Rep,2017,7:7617.
• [21] Giannakopoulos B,Krilis SA.The pathogenesis of the antiphospholipid syndrome[J].N Engl J Med,2013,368:1033- 1044.
• [22] Chi CM,Lau CS,Wong R.Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus[J].J Rheumatol,2001,28:766- 771.
• [23] Hanly JG,Harrison MJ.Management of neuropsychiatric lupus[J].Best Pract Res Clin Rheumatol,2005,19:799- 821.
• [24] Ezeoke A,Mellor A,Buckley P,et al.A systematic,quantitative review of blood autoantibodies in schizophrenia[J].Schizophrenia Research,2013,150:245- 251.
• [25] Tin SK,Xu Q,Thumboo J,et al.Novel brain reactive autoantibodies:prevalence in systemic lupus erythematosus and association with psychoses and seizures[J].J Neuroimmunol,2005,169:153- 160.
• [26] Mostafa GA,Nazif HK,El-Shahawi HH,et al.Antineuronal antibodies and electroneurophysiological studies in pediatric patients with neuropsychiatric systemic lupus erythematosus[J].Pediatr Allergy Immunol,2010,20:192- 199.
• [27] Greenwood DLV,Gitlits VM,Alderuccio F,et al.Autoantibodies in Neuropsychiatric Lupus[J].Autoimmunity,2002,35:79- 86.
• [28] Hirohata S,Arinuma Y,Yanagida T,et al.Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus[J].Arthritis Res Ther,2014,16:R77.
• [29] Diamond B,Volpe BT.A model for lupus brain disease[J].Immunol Rev,2012,248:56- 67.
• [30] Diamond B,Bloom O,Al AY,et al.Moving towards a cure:blocking pathogenic antibodies in systemic lupus erythematosus[J].J Intern Med,2011,269:36- 44.
• [31] Faust TW,Chang EH,Kowal C,et al.Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms[J].Proc Natl Acad Sci U S A,2010,107:18569- 18574.
• [32] Omdal R,Brokstad K,Waterloo K,et al.Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors[J].Eur J Neurol,2005,12:392- 398.
• [33] Hanly JG,Robichaud J,Fisk JD.Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus[J].J Rheumatol,2006,33:1553- 1558.
• [34] Harrison MJ,Ravdin LD,Lockshin MD.Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus[J].Arthritis Rheum,2006,54:2515- 2522.
• [35] Zandman-Goddard G,Chapman J,Shoenfeld Y.Autoantibodies Involved in Neuropsychiatric SLE and Antiphospholipid Syndrome[J].Semin Arthritis Rheum,2007,36:297- 315.
• [36] Terunuma M.Diversity of structure and function of GABAB receptors:a complexity of GABAB-mediated signaling[J].Proc Jpn Acad Ser B Phys Biol Sci,2018,94:390- 411.
• [37] Valesini G,Alessandri C,Celestino D,et al.Anti-endothelial antibodies and neuropsychiatric systemic lupus erythematosus[J].Ann N Y Acad Sci,2006,1069:118- 128.
• [38] Trysberg E,Nylen K,Rosengren LE,et al.Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement[J].Arthritis Rheum,2003,48:2881- 2887.
• [39] Alessandri C,Conti F,Valesini G.Role of anti-glial fibrillary acidic protein antibodies in the pathogenesis of neuropsychiatric systemic lupus erythematosus should be clarified:comment on the article by Trysberg et al[J].Arthritis Rheum,2004,50:1698- 1699,1699.
• [40] Williams RJ,Sugiura K,Tan EM.Antibodies to micro-tubule-associated protein 2 in patients with neuropsychiatric systemic lupus erythematosus[J].Arthritis Rheum,2004,50:1239- 1247.
• [41] Yamada Y,Nozawa K,Nakano S,et al.Antibodies to microtubule-associated protein- 2 in the cerebrospinal fluid are a useful diagnostic biomarker for neuropsychiatric systemic lupus erythematosus[J].Mod Rheumatol,2016,26:562- 568.
• [42] Song J,Park YB,Lee WK,et al.Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus[J].Rheumatol Int,2000,20:1- 7.
• [43] Meroni PL,Tincani A,Sepp N,et al.Endothelium and the brain in CNS lupus[J].Lupus,2003,12:919- 928.
• [44] Conti F,Alessandri C,Bompane D,et al.Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations:a role for anti-endothelial-cell antibodies[J].Arthritis Res Ther,2004,6:R366-R372.